Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Reuter, M. Becker, O. Arlt, N. Dehzad, H. Martin, A. Waisman, M. Stassen, R. Buhl, C. Taube (Mainz, Germany). The development of an allergic airway disease is influenced by a short splice variant of CYLD. Eur Respir J 2010; 36: Suppl. 54, 1348

Member's Comments

No comment yet.

Related content which might interest you: T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease Source: Annual Congress 2011 - T-cell subsets Year: 2011 A short splice variant of the tumor suppressor gene CYLD induces allergic airway disease in mice and is also expressed in humans Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Enhanced allergen capture and processing by dendritic cells and other airway APC precedes the onset of allergic airways disease Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Distinct epithelial phenotypes in child allergic respiratory disease are revealed by gene expression profiling Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Characterisation of type two immune responses in a murine model of allergic airway disease Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006 Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 CARD9S12N allele expression imbalance favors development of allergic bronchopulmonary aspergillosis Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 DPP10 protein expression is associated with the pathogenesis of asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 231s Year: 2005 Glutaredoxins in allergic airway disease and regulation by H2O2 in vivo Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005 Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 CpG oligodeoxynucleotide treatment prevents the development of airway remodelling in a murine model of chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 2s Year: 2002 T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Source: Eur Respir J 2007; 30: 383-390 Year: 2007 Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008